256 related articles for article (PubMed ID: 19289603)
21. Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice.
Pereira JA; Taniguti AP; Matsumura C; Marques MJ; Neto HS
Muscle Nerve; 2012 Sep; 46(3):400-6. PubMed ID: 22907231
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.
Hinchcliff M; Huang CC; Ishida W; Fang F; Lee J; Jafari N; Wilkes M; Bhattacharyya S; Leof E; Varga J
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S86-96. PubMed ID: 22691216
[TBL] [Abstract][Full Text] [Related]
23. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
24. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
25. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
26. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.
Xu DQ; Zhao L; Li SJ; Huang XF; Li CJ; Sun LX; Li XH; Zhang LY; Jiang ZZ
Acta Pharmacol Sin; 2021 Jul; 42(7):1080-1089. PubMed ID: 32939036
[TBL] [Abstract][Full Text] [Related]
27. Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
Mundhenke C; Weigel MT; Sturner KH; Roesel F; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Hilpert F; Jonat W; Maass N
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1397-405. PubMed ID: 18465140
[TBL] [Abstract][Full Text] [Related]
28. Fish oil attenuated dystrophic muscle markers of inflammation via FFA1 and FFA4 in the mdx mouse model of DMD.
Maciel Junior M; Camaçari de Carvalho S; Saenz Suarez PA; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2021 Jun; 304(6):1305-1312. PubMed ID: 33136305
[TBL] [Abstract][Full Text] [Related]
29. Nilotinib protects the murine liver from ischemia/reperfusion injury.
Ocuin LM; Zeng S; Cavnar MJ; Sorenson EC; Bamboat ZM; Greer JB; Kim TS; Popow R; DeMatteo RP
J Hepatol; 2012 Oct; 57(4):766-73. PubMed ID: 22641092
[TBL] [Abstract][Full Text] [Related]
30. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.
Eghtesad S; Jhunjhunwala S; Little SR; Clemens PR
Mol Med; 2011; 17(9-10):917-24. PubMed ID: 21607286
[TBL] [Abstract][Full Text] [Related]
32. Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies.
Sanarica F; Mantuano P; Conte E; Cozzoli A; Capogrosso RF; Giustino A; Cutrignelli A; Cappellari O; Rolland JF; De Bellis M; Denora N; Camerino GM; De Luca A
Pharmacol Res; 2019 Jul; 145():104260. PubMed ID: 31059789
[TBL] [Abstract][Full Text] [Related]
33. Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib.
Kinsella P; Howley R; Doolan P; Clarke C; Madden SF; Clynes M; Farrell M; Amberger-Murphy V
Exp Cell Res; 2012 Mar; 318(5):641-52. PubMed ID: 22285130
[TBL] [Abstract][Full Text] [Related]
34. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
[TBL] [Abstract][Full Text] [Related]
35. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
36. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
[TBL] [Abstract][Full Text] [Related]
37. Positive effects of bisphosphonates on bone and muscle in a mouse model of Duchenne muscular dystrophy.
Yoon SH; Sugamori KS; Grynpas MD; Mitchell J
Neuromuscul Disord; 2016 Jan; 26(1):73-84. PubMed ID: 26494410
[TBL] [Abstract][Full Text] [Related]
38. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
[TBL] [Abstract][Full Text] [Related]
39. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
40. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
Paniagua RT; Sharpe O; Ho PP; Chan SM; Chang A; Higgins JP; Tomooka BH; Thomas FM; Song JJ; Goodman SB; Lee DM; Genovese MC; Utz PJ; Steinman L; Robinson WH
J Clin Invest; 2006 Oct; 116(10):2633-42. PubMed ID: 16981009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
